리튬 및 발프로에이트 병용 처치가 PC12 세포에서 ERK1/2 인산화와 ELK1 및 C-FOS 전사활성에 미치는 영향

키워드

참고문헌 (58)

1. Cipriani A, "Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis", Lancet, 378, pp.1306~1315 (2011)
2. Cruz N, "Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis", Int J Neuropsychopharmacol, 13, pp.5~14 (2010)
3. Yatham LN, "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013", Bipolar Disord, 15, pp.1~44 (2013)
4. Goodwin GM, "Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology", J Psychopharmacol, 23, pp.346~348 (2009)
5. Freeman MP, "Mood stabilizer combinations: a review of safety and efficacy", Am J Psychiatry, 155, pp.12~21 (1998)
6. BALANCE investigators, "Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial", Lancet, 375, pp.385~395 (2010)
7. Chin PC, "Inhibition of GSK3beta is a common event in neuroprotection by different survival factors", Brain Res Mol Brain Res, 137, pp.193~201 (2005)
8. Machado-Vieira R, "The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis", Bipolar Disord, 11(Suppl 2), pp.92~109 (2009)
9. De Sarno P, "Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium", Neuropharmacology, 43, pp.1158~1164 (2002)
10. Hashimoto R, "Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity", Neuropharmacology, 43, pp.1173~1179 (2002)
11. Nonaka S, "Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats", Neuroreport, 9, pp.2081~2084 (1998)
12. Einat H, "The role of the extracellular signal-regulated kinase signaling pathway in mood modulation", J Neurosci, 23, pp.7311~7316 (2003)
13. Yan XB, "Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia", Neuropharmacology, 53, pp.487~495 (2007)
14. Kim AJ, "Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3", J Cell Sci, 118(Pt 1), pp.89~99 (2005)
15. Phiel CJ, "Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen", J Biol Chem, 276, pp.36734~36741 (2001)
16. Hao Y, "Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis", J Neurosci, 24, pp.6590~6599 (2004)
17. Dou H, "Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis", J Neurosci, 25, pp.8375~8385 (2005)
18. Kostrouchová M, "Valproic acid, a molecular lead to multiple regulatory pathways", wFolia Biol (Praha), 53, pp.37~49 (2007)
19. Zhang Y, "Downregulating the canonical Wnt", β-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress, 2012, pp.37, 1409~1419
20. Pardo R, "Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms", J Neurochem, 87, pp.417~426 (2003)
21. Johnson GL, "Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases", Science, 298, pp.1911~1912 (2002)
22. English JD, "Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation", J Biol Chem, 271, pp.24329~24332 (1996)
23. Sweatt JD, "Mitogen-activated protein kinases in synaptic plasticity and memory", Curr Opin Neurobiol, 14, pp.311~317 (2004)
24. Wu SP, "Involvement of mitogen-activated protein kinase in hippocampal long-term potentiation", J Biomed Sci, 6, pp.409~417 (1999)
25. Goldin M, "Protein kinase C and ERK involvement in dendritic spine plasticity in cultured rodent hippocampal neurons", Eur J Neurosci, 17, pp.2529~2539 (2003)
26. Wu GY, "Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology", Nat Neurosci, 4, pp.151~158 (2001)
27. Di Daniel E, "Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons", Bipolar Disord, 7, pp.33~41 (2005)
28. Kim SH, "Haloperidol regulates the phosphorylation level of the MEK-ERKp90RSK signal pathway via protein phosphatase 2A in the rat frontal cortex", Int J Neuropsychopharmacol, 11, pp.509~517 (2008)
29. Pozzi L, "Opposite regulation by typical and atypical anti-psychotics of ERK1", 2, CREB and Elk-1 phosphorylation in mouse dorsal striatum, 2003, pp.86, 451~459
30. Yuan PX, "The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth", J Biol Chem, 276, pp.31674~31683 (2001)
31. Dudbridge F, "Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data", Hum Hered, 66, pp.87~98 (2008)
32. Yuan P, "Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia", J Affect Disord, 124, pp.164~169 (2010)
33. Hsieh J, "Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells", Proc Natl Acad Sci U S A, 101, pp.16659~16664 (2004)
34. Michaelis M, "Valproic acid induces extracellular signal-regulated kinase 1", 2 activation and inhibits apoptosis in endothelial cells, 2006, pp.13, 446~453
35. Kopnisky KL, "Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities", Neuroscience, 116, pp.425~435 (2003)
36. Son H, "Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus", J Neurochem, 85, pp.872~881 (2003)
37. Chen G, "The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers", Curr Opin Psychiatry, 19, pp.313~323 (2006)
38. Besnard A, "Elk-1 a transcription factor with multiple facets in the brain", Front Neurosci, 5, pp.35~ (2011)
39. Ameyar M, "A role for AP-1 in apoptosis: the case for and against", Biochimie, 85, pp.747~752 (2003)
40. Karin M, "AP-1 function and regulation", Curr Opin Cell Biol, 9, pp.240~246 (1997)
41. Brunello N, "Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders", Int J Neuropsychopharmacol, 6, pp.181~189 (2003)
42. Asghari V, "Differential effects of mood stabilizers on Fos", Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells, 1998, pp.58, 95~102
43. Atmaca M, "Valproate and neuroprotective effects for bipolar disorder", Int Rev Psychiatry, 21, pp.410~413 (2009)
44. Atmaca M, "Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine", Psychol Med, 37, pp.121~129 (2007)
45. Drevets WC, "Neuroimaging studies of mood disorders", Biol Psychiatry, 48, pp.813~829 (2000)
46. Chiu CT, "Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder", Pharmacol Rev, 65, pp.105~142 (2013)
47. Chen G, "Enhancement of hippocampal neurogenesis by lithium", J Neurochem, 75, pp.1729~1734 (2000)
48. Laeng P, "The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells", J Neurochem, 91, pp.238~251 (2004)
49. Bachmann RF, "Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics", Mol Neurobiol, 32, pp.173~202 (2005)
50. McDonald C, "Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder", Biol Psychiatry, 56, pp.411~417 (2004)
51. Caetano SC, "Fronto-limbic brain abnormalities in juvenile onset bipolar disorder", Biol Psychiatry, 58, pp.525~531 (2005)
52. Dickstein DP, "Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study", Arch Gen Psychiatry, 62, pp.734~741 (2005)
53. Selemon LD, "Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder", Curr Mol Med, 3, pp.427~436 (2003)
54. Drevets WC, "Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders", Mol Psychiatry, 3, pp.220~226 (1998)
55. Todtenkopf MS, "A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain", Schizophr Res, 73, pp.79~89 (2005)
56. Moore GJ, "Lithium-induced increase in human brain grey matter", Lancet, 356, pp.1241~1242 (2000)
57. Guidotti A, "Characterization of the action of antipsychotic subtypes on valproate- induced chromatin remodeling", Trends Pharmacol Sci, 30, pp.55~60 (2009)
58. Machado-Vieira R, "Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions", CNS Neurosci Ther, 17, pp.699~704 (2011)

관련 논문AI추천